The estimated Net Worth of Partners L P/Ilbiotechnolog... is at least 39.4 百万$ dollars as of 18 February 2014. Partners Ilbiotechnolog owns over 422,900 units of Ligand Pharmaceuticals stock worth over 8,184,315$ and over the last 11 years Partners sold LGND stock worth over 31,214,249$.
Partners has made over 1 trades of the Ligand Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently Partners sold 422,900 units of LGND stock worth 31,214,249$ on 18 February 2014.
The largest trade Partners's ever made was selling 422,900 units of Ligand Pharmaceuticals stock on 18 February 2014 worth over 31,214,249$. On average, Partners trades about 422,900 units every 0 days since 2014. As of 18 February 2014 Partners still owns at least 79,390 units of Ligand Pharmaceuticals stock.
You can see the complete history of Partners Ilbiotechnolog stock trades at the bottom of the page.
Over the last 21 years, insiders at Ligand Pharmaceuticals have traded over 205,340,014$ worth of Ligand Pharmaceuticals stock and bought 2,116,600 units worth 27,601,439$ . The most active insiders traders include Partners L P/Ilbiotechnolog...、Partners L P/Ilbiotechnolog...、Partners L P/Ilbiotechnolog.... On average, Ligand Pharmaceuticals executives and independent directors trade stock every 22 days with the average trade being worth of 2,239,733$. The most recent stock trade was executed by Octavio Espinoza on 28 August 2024, trading 753 units of LGND stock currently worth 50,090$.
ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
Ligand Pharmaceuticals executives and other stock owners filed with the SEC include: